NPCE
Neuropace Inc
NASDAQ: NPCE · HEALTHCARE · MEDICAL DEVICES
$16.86
+1.93% today
Updated 2026-04-30
Market cap
$585.64M
P/E ratio
—
P/S ratio
5.86x
EPS (TTM)
$-0.66
Dividend yield
—
52W range
$8 – $19
Volume
0.2M
Neuropace Inc (NPCE) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Operating cash flow | $-25.03M | $-21.61M | $-24.58M | $-36.87M | $-19.70M | $-17.95M | $-11.01M |
| Capital expenditures | $468000.00 | $62000.00 | $384000.00 | $603000.00 | $173000.00 | $306000.00 | $332000.00 |
| Depreciation | — | — | — | — | — | — | — |
| Stock-based comp | $1.44M | $1.38M | $4.29M | $8.35M | $9.56M | $10.28M | $11.09M |
| Free cash flow | $-25.49M | $-21.67M | $-24.96M | $-37.47M | $-19.87M | $-18.25M | $-11.34M |
| Investing cash flow | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — |
| Net change in cash | — | — | $-7.45M | $-12.58M | — | — | — |